Your browser doesn't support javascript.
loading
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
Menzies, Alexander M; Amaria, Rodabe N; Rozeman, Elisa A; Huang, Alexander C; Tetzlaff, Michael T; van de Wiel, Bart A; Lo, Serigne; Tarhini, Ahmad A; Burton, Elizabeth M; Pennington, Thomas E; Saw, Robyn P M; Xu, Xiaowei; Karakousis, Giorgos C; Ascierto, Paolo A; Spillane, Andrew J; van Akkooi, Alexander C J; Davies, Michael A; Mitchell, Tara C; Tawbi, Hussein A; Scolyer, Richard A; Wargo, Jennifer A; Blank, Christian U; Long, Georgina V.
Afiliación
  • Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Amaria RN; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Rozeman EA; Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Huang AC; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tetzlaff MT; Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van de Wiel BA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Lo S; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA.
  • Tarhini AA; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Burton EM; Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Pennington TE; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Saw RPM; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Xu X; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Karakousis GC; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ascierto PA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Spillane AJ; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • van Akkooi ACJ; Royal Prince Alfred Hospital, Sydney, Australia.
  • Davies MA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
  • Mitchell TC; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Tawbi HA; Royal Prince Alfred Hospital, Sydney, Australia.
  • Scolyer RA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Wargo JA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Blank CU; Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy.
  • Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
Nat Med ; 27(2): 301-309, 2021 02.
Article en En | MEDLINE | ID: mdl-33558722
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteínas Proto-Oncogénicas B-raf / Melanoma / Recurrencia Local de Neoplasia Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteínas Proto-Oncogénicas B-raf / Melanoma / Recurrencia Local de Neoplasia Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2021 Tipo del documento: Article